| Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma (NCT02425605) | Yonsei University | 2014-12-03 |
| The Efficacy and Safety of Retreatment With TAI for Patients Who Showed TACE-resistant: a Randomized Controlled Trial (NCT02220088) | Sun Yat-sen University | 2014-12-01 |
| A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma (NCT02279719) | Sumitomo Pharma America, Inc. | 2014-12-01 |
| TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma (NCT01721941) | Scripps Clinic Cancer Center | 2014-12-01 |
| Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study) (NCT02311205) | Asan Medical Center | 2014-12-01 |
| hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse (NCT02960594) | Inovio Pharmaceuticals | 2014-12-01 |
| Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver (NCT02273362) | National Cancer Institute (NCI) | 2014-11-24 |
| Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation (NCT02424955) | Stanford University | 2014-11-18 |
| A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC) (NCT02240433) | Eli Lilly and Company | 2014-11-12 |
| Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver (NCT02288910) | Rush University Medical Center | 2014-11-01 |
| Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection (NCT02329821) | Samsung Medical Center | 2014-11-01 |
| Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular Carcinoma (NCT02304289) | University Hospital, Ghent | 2014-11-01 |
| A Trial on SBRT After Incomplete TAE or TACE Versus Exclusive TAE or TACE For Treatment of Inoperable HCC (NCT02323360) | Istituto Clinico Humanitas | 2014-11-01 |
| Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular Carcinoma (NCT02513199) | Icahn School of Medicine at Mount Sinai | 2014-11-01 |
| In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer (NCT01923233) | Mirror Biologics, Inc. | 2014-11-01 |
| Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer (NCT02101593) | Polaris Group | 2014-11-01 |
| Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors (NCT03176485) | University of Arizona | 2014-10-17 |
| Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions (NCT02156739) | M.D. Anderson Cancer Center | 2014-10-13 |
| Sorafenib Plus Vitamin K1 Versus Sorafenib in Advanced Hepatocellular Carcinoma (NCT02259647) | Institute of Liver and Biliary Sciences, India | 2014-10-01 |
| Primary Culture of Residual Specimens Obtained From Aspiration of Hepatic Tumor to Predict the Prognosis of the Patients (NCT02587793) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2014-10-01 |
| Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial Chemoembolization (NCT02552745) | Sun Yat-sen University | 2014-10-01 |
| Combine TACE and RFA Versus TACE Alone for HCC With PVTT (NCT02301091) | Ming Zhao | 2014-10-01 |
| RALPPS Venus ALPPS for Hepatocellular Carcinoma (NCT02299843) | Southwest Hospital, China | 2014-10-01 |
| Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation (NCT02399735) | Third Affiliated Hospital, Sun Yat-Sen University | 2014-10-01 |
| Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC) (NCT02128958) | Can-Fite BioPharma | 2014-09-01 |
| Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer (NCT02174549) | Teclison Ltd. | 2014-09-01 |
| Laparoscopic Hepatectomy and Radiofrequency Ablation in the Treatment of Early Hepatocellular Carcinoma (NCT02243384) | ChenJian | 2014-09-01 |
| A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma (NCT02178358) | Eli Lilly and Company | 2014-08-08 |
| Early-Phase Safety of Proton Therapy Equipment (NCT02315989) | Chang Gung Memorial Hospital | 2014-08-01 |
| Diffusion-Weighted Magnetic Resonance Imaging (NCT02242786) | Samsung Medical Center | 2014-08-01 |
| to Evaluate the Efficacy and Safety of MG4101(Ex Vivo Expanded Allogeneic NK Cell) (NCT02008929) | Samsung Medical Center | 2014-08-01 |
| Dendritic Killer Cell-based Immunotherapy for Solid Tumors (NCT02882659) | FullHope Biomedical Co., Ltd. | 2014-08-01 |
| A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma (NCT02210182) | Oncozyme Pharma Inc. | 2014-08-01 |
| 18F-FluoroethylCholine Positron Emission Tomography: a Promising Diagnostic Tool for Hepatocellular Carcinoma (NCT02238769) | Peking Union Medical College Hospital | 2014-07-01 |
| LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis (NCT02151864) | Jason K. Sicklick, M.D. | 2014-07-01 |
| Extracellular RNA Markers of Liver Disease and Cancer (NCT02908048) | Mayo Clinic | 2014-07-01 |
| A Prospective Control Study of Cidan Capsule Combined With TACE in Hepatocellular Carcinoma (NCT02253511) | Zheng Donghai | 2014-07-01 |
| Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery (NCT02174575) | Tokyo Medical and Dental University | 2014-07-01 |
| GEN2 Directed Cancer Immunotherapy Trial (NCT04313868) | GenVivo, Inc. | 2014-06-13 |
| Prospective Post Y90 Liver Hypertrophy (NCT02783261) | Singapore General Hospital | 2014-06-01 |
| Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC) (NCT02112656) | Imunon | 2014-06-01 |
| Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma (NCT02415036) | Delcath Systems Inc. | 2014-06-01 |
| Xihuang Capsules Prevention of Recurrence in Patients With Hepatocellular Carcinoma After Hepatectomy (NCT02399033) | Shuqun Cheng | 2014-06-01 |
| Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant (NCT02182687) | Lahey Clinic | 2014-06-01 |
| Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma (NCT02191878) | Arbutus Biopharma Corporation | 2014-06-01 |
| Hepatocellular Carcinoma in HIV-infected Patients (NCT02785835) | Hospital Universitario de Valme | 2014-05-01 |
| Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma (NCT02550613) | National Taiwan University Hospital | 2014-05-01 |
| Combination Treatment for Advanced Liver Cancer (NCT02149771) | Shanghai Zhongshan Hospital | 2014-05-01 |
| Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin (NCT02029690) | Polaris Group | 2014-04-23 |
| Efficacy and Safety Study of TLC388 to Advanced Hepatocellular Carcinoma (NCT02267213) | Taiwan Liposome Company | 2014-04-10 |
| Efficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Liver Cancer (NCT02089763) | Bio-Cancer Treatment International Limited | 2014-04-01 |
| Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC (NCT02089633) | Bio-Cancer Treatment International Limited | 2014-04-01 |
| Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma (NCT02109146) | Zhejiang University | 2014-03-26 |
| Prevention of Hand-foot Skin Reaction (NCT04568330) | Taipei Veterans General Hospital, Taiwan | 2014-03-21 |
| Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma (NCT02269995) | Eisai Co., Ltd. | 2014-03-06 |
| Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection (NCT01914263) | Alliancells-PuRui Biocience Co., Ltd. | 2014-03-01 |
| Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma (NCT02755311) | Sun Yat-sen University | 2014-03-01 |
| Liver and Biliary Tumor Tissue Registry (NCT02917759) | Mayo Clinic | 2014-02-01 |
| Pretreatment MRI Predicting Outcome After Radio-frequency Ablation of HCC (NCT02051283) | Universitaire Ziekenhuizen KU Leuven | 2014-02-01 |
| Doxorubicin-eluting LC Bead M1 for Patients With Hepatocellular Carcinoma (NCT02007954) | Yale University | 2014-02-01 |
| To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma (NCT02074202) | National Taiwan University Hospital | 2014-02-01 |
| Comparison of Response and Recurrence Rates Following Percutaneous Microwave Coagulation Therapy Versus Percutaneous Radiofrequency Ablation (NCT02859753) | Centre Hospitalier Universitaire Dijon | 2014-01-15 |
| Circulating Cell-free DNA as a Predictive Biomarker for Hepatocelluar Carcinoma. (NCT02036216) | Peking Union Medical College Hospital | 2014-01-01 |
| The Effects of Vitamin B-6 and Coenzyme Q10 Status on Oxidative Stress, Antioxidant Capacities, and Inflammatory Responses in Patients With Liver Cancer (NCT01964001) | Taichung Veterans General Hospital | 2014-01-01 |
| Recurrence Risk Factors of Early-Stage Hepatocellular Carcinoma After Radio Frequency Ablation (NCT02046356) | Yunhua Tan | 2014-01-01 |
| Robotic Versus Laparoscopic Liver Resection for Hepatocellular Carcinoma (NCT06496113) | Ente Ospedaliero Cantonale, Bellinzona | 2014-01-01 |
| Pathological Results of Aggressive Hepatocellular Carcinomas Treated Using SIRT (NCT05045573) | University Hospital, Montpellier | 2014-01-01 |
| Assessment of Novel MRI Quantification Free Breathing Technique in Evaluation of Liver Lesions (NCT02095678) | Case Comprehensive Cancer Center | 2013-12-01 |
| 24hr Imaging Of HCC After EOVIST (NCT01968629) | Massachusetts General Hospital | 2013-12-01 |
| An Individualized Anti-Cancer Vaccine Study in Patients With HCC (NCT01995227) | Mirror Biologics, Inc. | 2013-12-01 |
| Radiofrequency-assisted Hepatectomy on the Outcomes of HCC Patients With Cirrhosis (NCT01992978) | Southwest Hospital, China | 2013-11-01 |
| Interest of Functional MRI (Magnetic Resonance Imagery) (in Patients Suffering From Hepatocellular Carcinoma and Treated With Yttrium (NCT02003339) | Center Eugene Marquis | 2013-11-01 |
| Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT (NCT01825213) | Massachusetts General Hospital | 2013-11-01 |
| Phase 1-2 Trial HCQ Plus TACE in Unresectable HCC (NCT02013778) | Abramson Cancer Center at Penn Medicine | 2013-11-01 |
| Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients (NCT02113865) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2013-10-01 |
| Prospective, Observational Study of Biomarkers in Liver Cancer - Identification of Actionable Events (NCT01963949) | University of Texas Southwestern Medical Center | 2013-10-01 |
| Phase I Safety Study of Dendritic Cell Vaccine to Treat Patients With Hepatocellular Carcinoma (NCT01974661) | Mendus | 2013-10-01 |
| A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCC (NCT01997957) | Zhu Xu | 2013-10-01 |
| A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine Green (NCT01962649) | Massachusetts General Hospital | 2013-10-01 |
| Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib (NCT01908426) | Exelixis | 2013-09-26 |
| Study of High-Dose Oral Vitamin D for the Prevention of Liver Cancer (NCT01956864) | Johns Hopkins University | 2013-09-01 |
| Sorafenib Chemoembolization Evaluation Controlled Trial (NCT01906216) | Air Force Military Medical University, China | 2013-09-01 |
| Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors (NCT02156700) | University Hospital Dubrava | 2013-09-01 |
| Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC (NCT01229839) | Sun Yat-sen University | 2013-08-01 |
| Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery (NCT01936233) | Fudan University | 2013-08-01 |
| Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion (NCT01901692) | Asan Medical Center | 2013-07-29 |
| TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma (NCT01833286) | Sun Yat-sen University | 2013-07-01 |
| Surgical Specification and Efficacy Evaluation of Total Laparoscopic Left Liver Resection (NCT02131441) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2013-07-01 |
| Multiple Antigen Specific Cell Therapy (MASCT) for Hepatocellular Carcinoma(HCC) Patients After Radical Resection or Radio Frequency Ablation(RFA). (NCT02026362) | HRYZ Biotech Co. | 2013-07-01 |
| TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients (NCT01918683) | Abramson Cancer Center at Penn Medicine | 2013-07-01 |
| Comparison of TACE Versus TACE/TACI Combination in Advanced Hepatocellular Carcinoma With Portal Vein Invasion (NCT01857726) | Seoul National University Hospital | 2013-07-01 |
| Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma (NCT01924624) | The First Affiliated Hospital of Xiamen University | 2013-07-01 |
| Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication (NCT01894269) | Sun Yat-sen University | 2013-07-01 |
| Hepatocellular Carcinoma Using Stereotactic Body Radiotherapy (NCT01850316) | British Columbia Cancer Agency | 2013-07-01 |
| Effect of Colchicine for the Palliative Management of Hepatocellular Carcinoma (NCT01935700) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2013-06-06 |
| Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients. (NCT01890291) | GC Cell Corporation | 2013-06-01 |
| TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial (NCT03636620) | Fudan University | 2013-06-01 |
| Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI) (NCT01871545) | Icahn School of Medicine at Mount Sinai | 2013-06-01 |
| DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC (NCT01806740) | Guerbet | 2013-05-09 |
| Radioembolization for Hepatocellular Carcinoma With Portal Vein Tumoral Thrombosis (NCT04771988) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2013-05-08 |